Internal Medicine, Pulmonary Disease · New Castle, PA
NPI
1073563466
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
2602 Wilmington Rd, Suite 102
New Castle, PA, 16105
Phone (724) 657-5285
Groups this clinician bills Medicare through
Medicare paid, 2024
$152K
1,786 services
Medicare patients, 2024
232
Average age 73
Drug cost, 2024
$2.7M
11,254 prescriptions
Company payments, 2025
$262
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ramesh Kaul was code 99233 (hospital e&m - subsequent), 607 times for 51 patients. In total Ramesh Kaul billed 1,786 services in 42 codes, and Medicare paid $152K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 607 | 51 | $88.61 | $54K |
| 99215 Office E&M - Established | Office | 276 | 129 | $117.87 | $33K |
| 99214 Office E&M - Established | Office | 100 | 46 | $83.35 | $8,335 |
| 99291 Critical Care E&M | Facility | 93 | 17 | $160.12 | $15K |
| 99309 SNF E&M | Facility | 87 | 17 | $71.50 | $6,221 |
| 94729 Pulmonary Function Testing | Office | 56 | 56 | $38.51 | $2,157 |
| 94726 Pulmonary Function Testing | Office | 56 | 56 | $38.99 | $2,184 |
| 99223 Hospital E&M - Initial | Facility | 52 | 38 | $126.38 | $6,572 |
| 99310 SNF E&M | Facility | 51 | 17 | $101.52 | $5,178 |
| 94060 Pulmonary Function Testing | Office | 43 | 43 | $26.15 | $1,124 |
| 99205 Office E&M - New | Office | 36 | 36 | $154.98 | $5,579 |
| 94010 Pulmonary Function Testing | Office | 15 | 15 | $20.07 | $301 |
| 94621 Pulmonary Function Testing | Facility | 14 | 14 | $50.84 | $712 |
By year: 2022 $158K for 1,984 services; 2023 $165K for 1,882 services; 2024 $152K for 1,786 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ramesh Kaul prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 930 prescriptions and refills. In total Ramesh Kaul wrote 11,254 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 930 | 1,076 | 259 | $31K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 924 | 987 | 172 | $618K |
| Azithromycin Generic | 468 | 769 | 235 | $4,352 |
| Prednisone Generic | 449 | 532 | 187 | $1,607 |
| Atorvastatin Calcium Generic | 317 | 341 | 46 | $7,085 |
| Montelukast Sodium Generic | 258 | 514 | 67 | $2,564 |
| Cefuroxime Cefuroxime Axetil | 257 | 257 | 162 | $3,761 |
| Breo Ellipta Fluticasone/Vilanterol | 248 | 267 | 48 | $101K |
| Eliquis Apixaban | 227 | 249 | 23 | $83K |
| Fluticasone Propionate Generic | 210 | 266 | 53 | $3,716 |
| Tamsulosin Hcl Generic | 190 | 208 | 28 | $4,915 |
| Ventolin Hfa Albuterol Sulfate | 174 | 202 | 48 | $11K |
| Amlodipine Besylate Generic | 169 | 195 | 28 | $2,766 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 156 | 158 | 33 | $99K |
| Theophylline Er Theophylline Anhydrous | 154 | 226 | 26 | $9,933 |
Brand drugs: 3,816 claims; generic drugs: 7,418 claims; opioid claims: 79.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ramesh Kaul $262 ($262 in general payments such as food, travel and fees) from 8 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $91.76.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $91.76 |
| Verona Pharma, Inc. VRNA | 2 | $35.62 |
| Genzyme Corporation SNY | 1 | $34.09 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $22.45 |
| United Therapeutics Corporation UTHR | 1 | $21.32 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $19.3 |
| Lilly USA, LLC LLY | 1 | $19 |
| ANI Pharmaceuticals, Inc. ANIP | 1 | $18.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.